M2 macrophages phagocytose rituximab-opsonized leukemic targets more efficiently than m1 cells in vitro. (Q39870660)

From Wikidata
Jump to navigation Jump to search
scientific article published on April 2009
edit
Language Label Description Also known as
English
M2 macrophages phagocytose rituximab-opsonized leukemic targets more efficiently than m1 cells in vitro.
scientific article published on April 2009

    Statements

    M2 macrophages phagocytose rituximab-opsonized leukemic targets more efficiently than m1 cells in vitro (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit